Medical weight loss means a clinician evaluates your weight-related health and may prescribe an FDA-approved medicine alongside diet and activity changes.
An older city changes the coverage math
Census figures put Scottsdale's 65-and-older share at 26.4%, more than double Phoenix's 12.2% [1]. In Maricopa County, which includes both cities, 30.4% of adults have obesity and 10.6% have diagnosed diabetes [4]. Arizona Medicaid does not cover GLP-1s for obesity [5], so the coverage that matters most locally is Medicare.
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Scottsdale, from $300 a month.
A local practice can buy the sponsored slot. It is marked sponsored, and the payment buys no recommendation from us.
The Medicare GLP-1 Bridge, step by step
- Confirm you have Medicare Part D. The Bridge runs outside the Part D benefit but requires Part D coverage [2].
- Check the BMI rules: 35 or higher; or 30 or higher with heart failure with preserved ejection fraction, uncontrolled high blood pressure or stage 3a+ kidney disease; or 27 or higher with prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease [2].
- Your prescriber requests prior authorization, which Humana processes centrally with a decision within 72 hours [6].
- Fill Wegovy (pen or pill), Foundayo or the Zepbound KwikPen for $50 a month. Zepbound vials and single-dose pens and Ozempic are not covered [6].
Tirzepatide in Scottsdale
Scottsdale adults under 65, or who miss the Bridge criteria, can buy Zepbound from LillyDirect: $299 a month at 2.5 mg, $399 at 5 mg, and $449 at 7.5 to 15 mg as long as each refill lands within 45 days [7]. In SURMOUNT-1 the 15 mg group averaged 20.9% weight loss over 72 weeks [8]. See tirzepatide and Zepbound cost.
Cash and copay figures side by side
| Route | Monthly | Source |
|---|---|---|
| Foundayo tablets, LillyDirect | $149 to $299 | [9] |
| Wegovy tablets, NovoCare | $149 to $299 | [3] |
| Wegovy injection, NovoCare | $349 | [3] |
| Zepbound 7.5 to 15 mg, LillyDirect | $449 if refilled within 45 days | [7] |
| Medicare GLP-1 Bridge | $50 copay | [2] |
Local systems and what we could confirm
Scottsdale health systems include HonorHealth and Mayo Clinic's Arizona campus, home to Mayo Clinic Executive Health at 13400 E. Shea Blvd. We found no posted medical weight loss price at either. Look up any prescriber with the Arizona Medical Board [10], and use our clinic checklist and weight loss guide. Elsewhere in the Southwest: Phoenix, Tucson, Salt Lake City and Las Vegas.
Label warnings for older patients
Both labels list pancreatitis, so abdominal pain that is intense and lingers needs care [11] [12]. Retirees on insulin or a sulfonylurea should ask their prescriber about low blood sugar. A swollen face, lips or throat can mean an allergic reaction. The boxed warning on thyroid C-cell tumors means these drugs are off limits with MEN 2 or a personal or family history of medullary thyroid carcinoma. Stop if a pregnancy is recognized. Emergencies go to 911.
Questions people ask
How do Scottsdale retirees qualify for the $50 Medicare GLP-1 Bridge?
What does Zepbound cost a Scottsdale cash buyer?
LillyDirect charged $299 to $449 a month by dose on Oct 17, 2026 [7].
How much older is Scottsdale than Phoenix?
Census QuickFacts puts Scottsdale's 65-and-over share at 26.4%, more than double Phoenix's 12.2% [1].
Will Arizona Medicaid pay for weight loss GLP-1s in Scottsdale?
No. Arizona was missing from KFF's January 2026 count of 13 state Medicaid programs covering GLP-1s for obesity [5].
Which Zepbound form does the Medicare Bridge accept?
Only the Zepbound KwikPen. Single-dose vials and pens are excluded, as is Ozempic [6].
How many people live in Scottsdale?
243,006 as of July 2025, per the Census Bureau [1].
Sources
12 cited
- QuickFacts: Scottsdale city, Arizona. U.S. Census Bureau, 2025 estimates and 2020-2024 ACS; accessed 2026-10-17.
- Weight loss drugs coverage (Medicare GLP-1 Bridge). Medicare.gov (CMS), accessed 2026-10-17.
- Wegovy self-pay offer, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- PLACES data, county, 2025 release: Maricopa County, AZ. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
- Medicaid coverage of and spending on GLP-1s. KFF, Jan 16, 2026.
- Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, accessed 2026-10-17.
- Zepbound self-pay prices on LillyDirect. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine (PubMed), 2022.
- Foundayo self-pay prices on LillyDirect. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
- Arizona Medical Board. State of Arizona, accessed 2026-10-17.
- Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration, Apr 2026.
- Wegovy label (injection and tablets). DailyMed, National Library of Medicine, Jun 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.